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a b s t r a c t
The endocardium forms the inner lining of the heart tube, where it enables blood ﬂow and also interacts
with the myocardium during the formation of valves and trabeculae. Although a number of studies have
identiﬁed regulators in the morphogenesis of the myocardium, relatively little is known about the
molecules that control endocardial morphogenesis. Prior work has implicated the bHLH transcription
factor Tal1 in endocardial tube formation: in zebraﬁsh embryos lacking Tal1, endocardial cells form a
disorganized mass within the ventricle and do not populate the atrium. Through blastomere transplan-
tation, we ﬁnd that tal1 plays a cell-autonomous role in regulating endocardial extension, suggesting that
Tal1 activity inﬂuences the behavior of individual endocardial cells. The defects in endocardial behavior
in tal1-deﬁcient embryos originate during the earliest steps of endocardial morphogenesis: tal1-deﬁcient
endocardial cells fail to generate a cohesive monolayer at the midline and instead pack tightly together
into a multi-layered aggregate. Moreover, the tight junction protein ZO-1 is mislocalized in the tal1-
deﬁcient endocardium, indicating a defect in intercellular junction formation. In addition, we ﬁnd that
the tal1-deﬁcient endocardium fails to maintain its identity; over time, a progressively increasing
number of tal1-deﬁcient endocardial cells initiate myocardial gene expression. However, the onset of
defects in intercellular junction formation precedes the onset of ectopic myocardial gene expression in
the tal1-deﬁcient endocardium. We therefore propose a model in which Tal1 has distinct roles in
regulating the formation of endocardial intercellular junctions and maintaining endocardial identity.
& 2013 Elsevier Inc. All rights reserved.
Introduction
In its initial embryonic form, the vertebrate heart is a simple two-
layered tube, in which an outer layer of muscular myocardium
surrounds an inner layer of vascular endocardium. Both layers of
the heart tube are essential for cardiac function: while the myocar-
dium is responsible for the contractility that propels circulation, its
endocardial lining provides continuity with the rest of the embryonic
vessels. Furthermore, signaling between the endocardium and myo-
cardium plays a fundamental role in controlling later steps of
chamber growth, valve formation, and trabeculation (Chang et al.,
2004; Delaughter et al., 2011; Stankunas et al., 2008; Wagner and
Siddiqui, 2007). Therefore, the mechanisms controlling assembly of
the two-layered heart tube are of great interest.
In all vertebrates, heart tube assembly begins with the migra-
tion of bilateral groups of endocardial and myocardial cells from
the anterior lateral plate mesoderm (ALPM) to the embryonic
midline (Evans et al., 2010). In amniotes, migrating endocardial
cells seem to attach to the medial endoderm, where they will
eventually merge into a central vessel (Aleksandrova et al., 2012;
DeRuiter et al., 1992; Drake et al., 2006; Viragh et al., 1989). At the
same time, cardiomyocytes meet at the midline to form the
cardiac crescent, which then remodels into a myocardial tube that
encases the endocardium (Abu-Issa and Kirby, 2008; DeRuiter
et al., 1992; Moreno-Rodriguez et al., 2006).
Similar processes of myocardial and endocardial fusion take
place in the zebraﬁsh, where time-lapse analyses have been
valuable in revealing the patterns of cell movement that underlie
heart tube assembly (Baker et al., 2008; Bussmann et al., 2007; de
Campos-Baptista et al., 2008; Fish et al., 2011; Holtzman et al.,
2007; Proulx et al., 2010; Rohr et al., 2008; Smith et al., 2008).
In zebraﬁsh, bilateral populations of endocardial cells move
toward the midline, where they assemble a sheet of tissue
(Bussmann et al., 2007). The migrating cardiomyocytes form a
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ring surrounding and dorsal to the endocardial sheet, setting up
the initial orientation of endocardium within the myocardium
(Holtzman et al., 2007; Motoike et al., 2000; Stainier et al., 1993).
Subsequently, endocardial and myocardial cells move toward the
left side of the embryo and then extend to create the two-layered
structure of the heart tube (Rohr et al., 2008).
The dynamic changes in tissue organization that occur during
heart tube assembly raise a number of intriguing questions about
the genetic regulation of this aspect of cardiac morphogenesis.
For example, we do not yet fully understand how cardiac cells are
recruited toward the midline, what conﬁgures the architecture of the
endocardial sheet and myocardial ring, or which factors control the
transition toward leftward movement and extension. In the case of
the myocardium, several requirements for these processes have been
revealed. Studies of zebraﬁsh and mouse mutations that impair
cardiac fusion have revealed that both the endoderm and the
extracellular matrix are required for the initial migration of the
myocardium and the formation of a central myocardial ring
(Alexander et al., 1999; Arrington and Yost, 2009; Garavito-Aguilar
et al., 2010; George et al., 1997, 1993; Kuo et al., 1997; Kupperman
et al., 2000; Molkentin et al., 1997; Trinh and Stainier, 2004). In
addition, Nodal and BMP signaling have been shown to be important
for the leftward migration of myocardial cells (de Campos-Baptista
et al., 2008; Lenhart et al., 2013; Rohr et al., 2008; Smith et al., 2008;
Veerkamp et al., 2013).
Less is known about the mechanisms that regulate endocardial
tube formation. Like the myocardium, the endocardium requires
interactions with the endoderm to facilitate its movement toward
the midline (Alexander et al., 1999; Holtzman et al., 2007; Sugi and
Markwald, 1996, 2003). Additionally, Slit/Robo and Vegf signaling
have been shown to inﬂuence the medial migration of both the
endocardium and the myocardium (Fish et al., 2011). However,
the genes responsible for organizing the endocardial sheet and
directing its transition as it lines the heart tube remain largely
mysterious.
It is therefore interesting to investigate the functions of Tal1, a
bHLH transcription factor that has been implicated in endocardial
morphogenesis (Bussmann et al., 2007). Tal1 (also known as Scl)
was originally characterized as a key player in the speciﬁcation of
hematopoietic lineages (Begley et al., 1989; Dooley et al., 2005;
Juarez et al., 2005; Patterson et al., 2005; Porcher et al., 1996; Robb
et al., 1995; Shivdasani et al., 1995). In addition, Tal1 is important
for the formation of major embryonic blood vessels (Dooley et al.,
2005; Patterson et al., 2005; Visvader et al., 1998). More recently,
studies of a zebraﬁsh tal1 mutant have revealed a phenotype in
which endocardial cells aggregate in the ventricular portion of the
heart tube and fail to populate the atrial portion (Bussmann et al.,
2007). Thus, Tal1 has a potent inﬂuence on the formation of the
endocardial tube, but the initial causes of the endocardial aggre-
gation in tal1 mutants are not yet clear.
Here, we investigate the impact of tal1 on the cell behaviors
that govern endocardial tube formation. Despite the well-known
role of tal1 in hematopoietic speciﬁcation, tal1 does not seem to be
required for the speciﬁcation of an appropriate number of endo-
cardial cells. Instead, we ﬁnd that tal1 plays a cell-autonomous
role in regulating endocardial cell behavior. Furthermore, we ﬁnd
that the endocardial defects in tal1-deﬁcient embryos originate
with the disorganization of cell–cell contacts and intercellular
junctions within the endocardial sheet at the midline. In addition,
we ﬁnd that tal1 is required for the maintenance of endocardial
identity; loss of tal1 function leads to a progressive accumulation
of ectopic myocardial gene expression in the endocardium. Since
the onset of defects in intercellular junction formation precedes
the accumulation of ectopic myocardial gene expression in tal1-
deﬁcient embryos, our work suggests that Tal1 has distinct roles in
regulating the formation of endocardial intercellular junctions and
maintaining endocardial identity.
Materials and methods
Zebraﬁsh
We used the following established transgenic and mutant lines:
Tg(kdrl:GRCFP) (Cross et al., 2003), Tg(ﬂi1a:negfp)y7 (Roman et al.,
2002), Tg(kdrl:HsHRAS-mCherry)s896 (Chi et al., 2008), Tg(-0.8myl7:
DsRed.T4)sk74 (Garavito-Aguilar et al., 2010), and hans6 (Yelon et al.,
2000). The Tg(myl7:H2A-mCherry) transgene was assembled using
Gateway constructs to place the myl7 promoter upstream of the
chimeric reporter H2A-mCherry (Kwan et al., 2007; Lin et al.,
2012). Transgenic founders were established using standard tech-
niques for Tol2-based transgenesis (Fisher et al., 2006), and were
bred to isolate single stable integrants. We examined 4 indepen-
dent integrants and found identical patterns of mCherry ﬂuores-
cence in each case. Speciﬁcally, ﬂuorescent nuclei were observed
in a domain matching the ﬂuorescent cells observed in Tg(myl7:
EGFP)twu277 (Huang et al., 2003) embryos at all developmental
stages examined between the 19 somite stage (19s) and 72 h post-
fertilization (hpf) (data not shown). We selected one of these
representative transgenic lines, Tg(myl7:H2A-mCherry)sd12, to pro-
pagate for further work.
Morpholino injection
The tal1 E2I2 and E3I3 morpholinos (MOs) used in our studies
were previously characterized and shown to be effective and
speciﬁc; moreover, they phenocopy all aspects of the tal1 mutant
phenotype (Bussmann et al., 2007; Juarez et al., 2005). We injected
12.5 ng of a 2:3 mix of E2I2 and E3I3 MOs into 1-cell stage
embryos as previously described (Schoenebeck et al., 2007).
Transplantation
Blastomere transplantation was performed at the midblastula
stage as previously described (Garavito-Aguilar et al., 2010). 75–100
cells were removed from Tg(kdrl:GRCFP) donor embryos and placed
into the margin of either non-transgenic or Tg(kdrl:HsHRAS-mCherry)
host embryos. For transplantation into non-transgenic hosts,
rhodamine-dextran was injected into donors as a lineage tracer.
We scored contribution to the endocardium at 24 hpf, and we
checked chimeras again at 48 hpf to score contribution to individual
chambers.
In situ hybridization and immunoﬂuorescence
Whole mount in situ hybridization for ﬂi1a (ZDB-GENE-980526-
426) was performed using standard protocols (Yelon et al., 1999). For
immunoﬂuorescence, we employed MF20 supernatant (1:10; Devel-
opmental Studies Hybridoma Bank), chicken anti-GFP (1:1000;
Abcam 13970), rabbit anti-GFP (1:500; Invitrogen A-11122), rabbit
anti-DsRed (1:4000; Clontech 632496) rabbit anti-Fibronectin
(1:100; Sigma F3648), mouse anti-β-catenin (1:500: Sigma C7207),
and mouse anti-ZO-1 (1:200; Zymed 33-9100) as primary antibodies,
followed by goat anti-mouse IgG2b TRITC, goat anti-rabbit FITC, goat
anti-mouse Cy5 (Southern Biotech), goat anti-mouse Alexa 647, goat
anti-chicken Alexa 488, and goat anti-rabbit Alexa 594 (Invitrogen) as
secondary antibodies. We used a previously described protocol for
whole mount immunoﬂuorescence (Alexander et al., 1998). For
cryosections, embryos were ﬁxed overnight in 4% paraformaldehyde
at 4 1C, followed by cryoprotection, mounting, sectioning, and
J.A. Schumacher et al. / Developmental Biology 383 (2013) 214–226 215
staining as performed previously (Garavito-Aguilar et al., 2010). Actin
was visualized using rhodamine phalloidin (1:50; Invitrogen R415),
which was incorporated into the secondary antibody stain.
Imaging and cell counting
Images were captured using Zeiss M2Bio and Axioplan micro-
scopes outﬁtted with Zeiss Axiocam cameras and processed using
Adobe Photoshop software. Confocal stacks were collected using
Zeiss LSM510 and Leica SP5 microscopes and analyzed using
Imaris software (Bitplane).
To determine the number of endocardial cells in wild-type and
tal1-deﬁcient hearts, we ﬂattened embryos carrying Tg(ﬂi1a:negfp)
under a cover slip and counted the number of endothelial nuclei
residing within the boundaries of the myocardium. We calculated
the mean and standard deviation for each cell number data set and
used a two-tailed, unpaired t-test to compare data sets.
To assess the percentage of endocardial cells expressing ectopic
myocardial markers in tal1-deﬁcient hearts, we compared the
number of endocardial nuclei expressing both Tg(myl7:H2A-
mCherry) and Tg(ﬂi1a:negfp) to the number of endocardial nuclei
expressing Tg(ﬂi1a:negfp). We scored every tenth optical section
from confocal stacks of individual hearts; between 3 and 10
sections were analyzed per heart.
Results
The endocardial aggregate in tal1-deﬁcient embryos is composed
of a normal number of endocardial cells
In order to investigate the cellular mechanisms through which
tal1 regulates endocardial morphogenesis, we have analyzed the
phenotype of zebraﬁsh embryos injected with anti-tal1 morpho-
linos (MOs). Embryos injected with these previously characterized
MOs recapitulate the defects observed in tal1 mutant embryos
(Bussmann et al., 2007; Juarez et al., 2005; Schoenebeck et al.,
2007). In particular, MO-injected embryos clearly display the same
endocardial defect seen in tal1 mutants: instead of forming an
inner layer that lines the entire heart tube, the endocardium
aggregates in a disorganized cluster in the ventricle and does
not populate the atrium (Fig. 1). To analyze the origins of this
defect, we employed MO-injected embryos (hereafter referred to
as tal1-deﬁcient embryos) in all of the experiments described
below.
Our ﬁrst step toward understanding the regulation of endocardial
morphogenesis by tal1 was to examine the inﬂuence of tal1 on
endocardial cell number. To determine whether the failure of the
tal1-deﬁcient endocardium to line the entire heart reﬂects a shortage
of endocardial cells in tal1-deﬁcient embryos, we counted endocar-
dial cells just after heart tube elongation (25–30 h post fertilization
(hpf)) (Fig. S1). We found that the average number of cells in wild-
type (59.1714.7; n¼69) and tal1-deﬁcient (58.6711.3; n¼72)
embryos was not signiﬁcantly different at this stage (p40.1). These
results indicate that tal1-deﬁcient embryos generate a normal
number of endocardial cells and that their endocardial extension
defects are not due to a deﬁciency in cell number.
tal1 acts cell autonomously to promote endocardial extension into the
atrium
Since tal1 is expressed in the endocardium (Bussmann et al.,
2007; Drake and Fleming, 2000; Elefanty et al., 1999; Zhang and
Rodaway, 2007), we reasoned that it could act in a cell-autonomous
fashion to control endocardial morphogenesis. Alternatively, tal1
could have an indirect impact on endocardial cell behavior, perhaps
Fig. 1. Endocardium fails to populate the atrium in tal1-deﬁcient embryos. (A–F) Lateral views of wild-type (WT) (A, C, and E) and tal1-deﬁcient hearts (B, D, and F) in live
embryos at 36 hpf; atrial end of the heart tube to the left. Three-dimensional reconstructions of confocal stacks depict myocardial cells expressing Tg(myl7:H2A-mCherry)
(red; A, B, E, and F) and endothelial cells, including the endocardium, expressing Tg(ﬂi1a:negfp) (green; A–D). In wild-type embryos (A and C), the endocardium fully lines the
myocardial tube, and extends past the atrium. In tal1-deﬁcient embryos (B and D), the endocardium is clumped within the ventricle (n¼151/158).
J.A. Schumacher et al. / Developmental Biology 383 (2013) 214–226216
through an inﬂuence on the endocardial environment. To assess the
cell-autonomy of tal1 function, we generated mosaic embryos
through blastomere transplantation (Fig. 2).
First, we examined the ability of donor-derived cells to con-
tribute to the endocardium, myocardium, and trunk endothelium
in wild-type host embryos. We found that tal1-deﬁcient donor
Fig. 2. tal1 promotes endocardial extension into the atrium in a cell-autonomous fashion. (A–N) Examples of mosaic embryos generated through blastomere transplantation;
lateral views, anterior to the left, at 48 hpf. Overlay of brightﬁeld and ﬂuorescent images indicates location of donor-derived cells. (A–D) Examples of wild-type donor-derived cells
expressing Tg(kdrl:GRCFP) (green) in wild-type non-transgenic hosts. (A and B) Wild-type donor-derived cells are located in the ventricular endocardium. (C and D) Wild-type
donor-derived cells (arrow) are located in the atrial endocardium. (E–H) Examples of tal1-deﬁcient cells expressing Tg(kdrl:GRCFP) in wild-type non-transgenic hosts. (E and F) tal1-
deﬁcient donor-derived cells are located in the ventricular endocardium. (G and H) A single tal1-deﬁcient donor-derived cell (arrow), weakly expressing Tg(kdrl:GRCFP), is located in
the atrial endocardium. We found only 2 such examples among our mosaic embryos (Table 1). (I–L) Examples of wild-type cells expressing Tg(kdrl:GRCFP) in tal1-deﬁcient non-
transgenic hosts. (I and J) Large number of wild-type donor-derived endocardial cells form a chain of cells through the ventricle (arrow), and extend to line the host atrium. (K and
L) Small number of wild-type donor-derived endocardial cells form a small tube of endocardium within the host atrium. (M and N) Example of wild-type cells expressing Tg(kdrl:
GRCFP) in a tal1-deﬁcient host expressing Tg(kdrl:HsHRAS-mCherry) (red). Wild-type donor-derived endocardial cells (green) populate the outﬂow tract and atrium, whereas tal1-
deﬁcient host endocardium (red) is clumped within the ventricle. (O) Pie charts indicate the relative contributions of donor-derived cells to the ventricular endocardium (white),
atrial endocardium (black), or ventricular and atrial endocardium (gray) within the mosaic embryos that exhibited donor-derived endocardium (Table 1).
Table 1
Transplantation experiments indicate a cell-autonomous role for tal1 during endocardial morphogenesis.
Transplant
type
Total endocardial
contribution
Atrial endocardial
contribution
Ventricular endocardial
contribution
Endothelial
contribution
Myocardial
contribution
WT to WT 15/184 (8.2%) 10/15 (66.7%) 9/15 (60.0%) 134/184 (72.8%) 37/214 (17.3%)
tal1 MO to WT 21/299 (7.0%) 2/21 (9.5%)n` 19/21 (90.5%) 103/299 (34.4% )n 52/451 (11.5%)
WT to tal1 MO 9/238 (3.8%) 8/9 (88.9%) 2/9 (22.2%) 185/238 (77.7%)
Each fraction reports the number of embryos in which donor cells contributed to a particular tissue divided by the total number of mosaic embryos scored. The fractions
representing atrial and ventricular endocardial contributions indicate the number of embryos in which donor cells contributed to the atrial or ventricular endocardium divided by
the total number of embryos displaying donor contribution to the endocardium. In some cases, donor cells contributed to both the ventricular and atrial endocardium (Fig. 2O).
Asterisks indicate statistically signiﬁcant differences from control transplants (wild-type into wild-type), as determined by Fisher's exact test (po0.05).
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cells contributed to the endocardium in 7% of our mosaic embryos,
a frequency similar to that observed for wild-type donor cells
(8.2%) (Table 1). This result suggests that tal1 is not required for
endocardial speciﬁcation, a conclusion consistent with our obser-
vation of normal endocardial cell number in tal1-deﬁcient
embryos (Fig. S1). Additionally, tal1-deﬁcient donor cells contrib-
uted to the myocardium in 11.5% of mosaic embryos, a frequency
comparable to that seen for wild-type donor cells (17.3%) (Table 1).
However, the frequency of contribution of tal1-deﬁcient donor
cells to trunk endothelium (34.4% of mosaic embryos) was
signiﬁcantly reduced in comparison to the contribution made by
wild-type donor cells (72.8%) (Table 1), consistent with the
previously demonstrated role for tal1 in vessel formation
(Dooley et al., 2005; Patterson et al., 2005; Visvader et al., 1998).
Next, we examined the relative contributions of donor cells to
the ventricular and atrial endocardium. Wild-type donor cells
contribute to the ventricular and atrial endocardium in wild-
type hosts with approximately the same frequency (60% vs.
67.7% of embryos displaying wild-type donor-derived endocardial
cells) (Table 1; Fig. 2A–D, O). In contrast, tal1-deﬁcient donor-
derived endocardial cells were nearly always found in the ventricle
of wild-type hosts (90.5% of embryos with tal1-deﬁcient donor-
derived endocardial cells) (Table 1; Fig. 2E, F, and O). We rarely
observed tal1-deﬁcient donor cells in the atrial endocardium of
wild-type hosts (Table 1); furthermore, in each of the 2 embryos in
which this was observed, we found only a single donor-derived
atrial endocardial cell with weak expression of Tg(kdrl:GRCFP)
(Fig. 2G and H). The inability of the wild-type host environment
to facilitate the contribution of tal1-deﬁcient cells to the atrial
endocardium strongly suggests that tal1 plays a cell-autonomous
role in promoting the extension of endocardial cells into the
atrium.
In addition, we performed the converse transplantation experi-
ment, placing wild-type blastomeres into tal1-deﬁcient host
embryos. Strikingly, in tal1-deﬁcient embryos, which lack atrial
endocardium, wild-type donor-derived endocardial cells were
frequently able to populate the atrium (Table 1; Fig. 2I and O).
Moreover, in hosts with large numbers of donor-derived endocar-
dial cells, wild-type donor cells were able to fully line the atrium
(Fig. 2I and J). In hosts with smaller numbers of donor-derived
endocardial cells, wild-type donor cells formed small tubes of
endocardium within the atrium (Fig. 2K and L). Interestingly, we
observed that wild-type donor-derived endocardial cells tend to
associate with each other and segregate away from tal1-deﬁcient
host endocardial cells, instead of mixing with them (Fig. 2M
and N). The ability of wild-type donor cells to contribute to the
Fig. 3. Defects in endocardial sheet formation appear after tal1-deﬁcient endocardial cells arrive at the midline. (A–F) Dorsal views of wild-type (A, C, and E) and tal1-deﬁcient
embryos (B, D, and F), anterior to the top, displaying the expression of ﬂi1a at the 18 somite (18s) (A and B), 20s (C and D), and 22s (E and F) stages. (A'–F') Cartoons indicate
regions of ﬂi1a expression in the endocardium (gray and black) and cranial endothelium (white). ﬂi1a expression in the branchial arches is visible in the images (A–F) but is not
indicated in the cartoons (A'–F'). (A, C, and E) In wild-type embryos, an endocardial sheet spreads along the anterior-posterior axis by 18s (A). Increased expression of ﬂi1a
becomes apparent at the future apex (black areas in C' and E') of the endocardial tube as the endocardial sheet transforms into a tube extending toward the left side of the
embryo (C and E). (B, D, and F) In tal1-deﬁcient embryos, the expression of ﬂi1a is maintained normally, consistent with previous reports (Patterson et al., 2005). Instead of
spreading out into a sheet, the tal1-deﬁcient endocardial cells aggregate at the midline (B) and subsequently fail to migrate toward the left (D and F).
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atrial endocardium in tal1-deﬁcient host embryos reinforced our
conclusion that tal1 is required cell autonomously in order for
endocardial cells to line the atrial chamber. In addition, our
experiments suggest that tal1 affects endocardial cell behaviors,
such as cell adhesion or movement, that impact the patterns of
intercellular interaction.
Early endocardial architecture is disrupted in tal1-deﬁcent embryos
To investigate the nature of the cell-intrinsic inﬂuence of tal1
on endocardial cell behavior, we proceeded to examine the origins
of the endocardial morphogenesis defects in tal1-deﬁcient
embryos. As previously documented in tal1 mutants (Bussmann
et al., 2007), loss of tal1 function does not seem to disrupt the
initial migration of endocardial cells from the anterior lateral plate
mesoderm (ALPM) to the embryonic midline (Fig. 3A and B).
However, defects in tal1-deﬁcient endocardial cell behavior
become evident once the cells reach the midline. In wild-type
embryos, endocardial cells that have arrived at the midline spread
out along the anterior-posterior axis to create a sheet of tissue
(Fig. 3A) (Bussmann et al., 2007). In contrast, tal1-deﬁcient cells do
not form a proper endocardial sheet: instead of spreading out
along the anterior-posterior axis, tal1-deﬁcient cells occupy a
smaller area at the midline (Fig. 3B).
Further examination of the cellular architecture of the endo-
cardium revealed that tal1 inﬂuences the arrangement and shape
of endocardial cells during sheet formation at the midline. In wild-
type embryos, the endocardial sheet is a single cell layer thick; in
addition, wild-type endocardial cells have a ﬂattened, elongated
appearance and only contact each other at their lateral edges (Fig. 4A,
C, E, G, and I). However, in tal1-deﬁcient embryos, endocardial
cells stack on top of one another to form a multi-layered aggregate
(Fig. 4B, D, F, H, and J). Additionally, tal1-deﬁcient endocardial cells
display a relatively rounded morphology and make contacts with
each other on their apical and basal surfaces as well as on their
lateral surfaces (Fig. 4B, D, F, H, and J).
Together, these results indicate that the endocardial morpho-
genesis defects in tal1-deﬁcient embryos originate with errors in
the formation of an endocardial sheet at the midline. Subse-
quently, tal1-deﬁcient endocardial cells fail to undergo the normal
process of leftward migration along the length of the extending
heart tube; instead, tal1-deﬁcient endocardial cells aggregate into
a dense cluster that ultimately resides within the ventricle
(Fig. 3C–F). Thus, the inability of tal1-deﬁcient endocardial cells
to populate the atrium suggests that the early architecture of the
endocardial sheet is an important prerequisite for normal endo-
cardial tube formation.
tal1 inﬂuences the distribution of endocardial intercellular junctions
The aberrant patterns of cell–cell contacts observed in tal1-
deﬁcient embryos led us to investigate whether tal1 inﬂuences the
Fig. 4. The architecture of the early endocardium is disrupted in tal1-deﬁcient embryos. (A–J) Transverse sections of wild-type (A, C, E, G, and I) and tal1-deﬁcient embryos
(B, D, F, H, and J), dorsal to the top, at 16s (A and B) and 18s (C–J). Immunoﬂuorescence detects localization of ﬁbronectin (FN; green) (E–H) and β-catenin (red) (E, F, I, and J);
in addition, an anti-GFP antibody allows visualization of Tg(kdrl:GRCFP) expression (blue) in the endocardium (A–F). Together, these markers highlight the shapes and
arrangement of the endocardial cells. Endocardial cells form a single-layered sheet of cells at 16s (A), after they have migrated to the midline, and this sheet of cells is
maintained at 18s (C). In tal1-deﬁcient embryos, endocardial cells stack on top of each other, forming a multi-layered cluster (B and D). The boxed areas in (C and D) are
highlighted in (E–J). The apical-basal polarity of wild-type endocardial cells (E) is indicated by basal deposition of FN (G) and apical enrichment of β-catenin (I). In tal1-
deﬁcient embryos (F), localization of FN (H) and β-catenin (J) highlight the dysmorphic endocardial architecture and aberrant cell shapes. (E'–J') Cartoons indicate regions of
FN (green) and β-catenin (red) localization within the endocardium. Endocardial cell outlines are marked in black. The FN and β-catenin that are presumed to be located
within the endoderm that overlies the endocardium are excluded from the cartoons.
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formation of intercellular junctions in the endocardium. We exa-
mined the subcellular localization of ZO-1, a core component of
the tight junction complex (Fanning and Anderson, 2009). In the
wild-type heart tube at 25 hpf, ZO-1 is found in discrete puncta at
the apical vertices connecting endocardial cells (Fig. 5C). In tal1-
deﬁcient embryos, ZO-1 is dramatically mislocalized, with broad
and irregular distribution around endocardial cell membranes
(Fig. 5D), whereas myocardial localization of ZO-1 appears unaf-
fected (Fig. 5A and B).
The irregular pattern of ZO-1 localization within the tal1-
deﬁcient endocardium could simply be a result of aberrant
endocardial cell packing within the ventricle, rather than being
an initial component of the morphogenesis defect in tal1-deﬁcient
embryos. To investigate whether tal1 inﬂuences tight junction
establishment during endocardial sheet formation, we examined
ZO-1 localization at 18s. In the wild-type endocardial sheet, ZO-1
is located in discrete puncta at apical-lateral cell–cell junctions
(Fig. 6A, C, D, and G), similar to its localization in the heart tube at
Fig. 5. Endocardial intercellular junctions are disorganized following heart tube extension in tal1-deﬁcient embryos. (A–D) Immunoﬂuorescence detects localization of ZO-1 (red)
in wild-type (A and C) and tal1-deﬁcient (B and D) hearts at 25 hpf; lateral views, ventricular end of the heart tube at the top. An anti-GFP antibody allows visualization of Tg(kdrl:
GRCFP) expression (green) in the endocardium. (A and B) Three-dimensional reconstructions of confocal stacks demonstrate that ZO-1 is located around the perimeter of the
myocardial cells in both wild-type and tal1-deﬁcient hearts. (C) Optical slice of a wild-type heart reveals that ZO-1 is localized in discrete puncta at points of endocardial cell-cell
contact; in addition, wild-type endocardial cells exhibit a ﬂattened and elongated morphology. (D) Optical slice of a tal1-deﬁcient heart reveals that ZO-1 is mislocalized in large
clusters around the perimeter of the endocardial cells; in addition, the tal1-deﬁcient endocardial cells exhibit a rounded shape, rather than the normal elongated shape. (E and F)
Immunoﬂuorescence detects ZO-1 (purple) in wild-type (E) and tal1-deﬁcient (F) hearts at 25 hpf; lateral views, ventricular end of the heart tube at the top. Expression of the Tg
(ﬂi1a:negfp) (green) and Tg(myl7:H2A-mCherry) (red) transgenes reveals one endocardial cell with ectopic myocardial gene expression (arrow). Subcellular localization of ZO-1 is
aberrant in the majority of tal1-deﬁcient endocardial cells, nearly all of which do not display ectopic myocardial gene expression.
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25 hpf. Even on occasions when wild-type endocardial cells were
found on top of one another instead of in a side-by-side orienta-
tion within the forming sheet, ZO-1 was found in individual
puncta at cell–cell vertices (Fig. S2). In contrast, ZO-1 is located
in multiple irregular puncta along the endocardial cell boundaries
of the multi-layered tal1-deﬁcient endocardium (Fig. 6B, E, F, and
H). These observations suggest that tal1 is required during endo-
cardial sheet formation to promote proper localization of inter-
cellular junctions.
tal1 is required for maintenance of endocardial identity
Recent studies in mouse have indicated that Tal1 is required for
the repression of myocardial differentiation within the endocardium
(Van Handel et al., 2012). Along the same lines, our previous studies
in zebraﬁsh have demonstrated that tal1, together with the ETS
family transcription factor gene etsrp, plays a critical role in inhibiting
myocardial speciﬁcation within the portion of the ALPM that
normally gives rise to the endocardium (Schoenebeck et al., 2007).
Together, these studies indicate the importance of Tal1 in repressing
myocardial gene expression within the endocardial lineage. There-
fore, we wondered whether a defect in endocardial identity assign-
ment or maintenance could be responsible for the morphogenetic
defects observed in the tal1-deﬁcient endocardium.
In order to examine whether ectopic myocardial differentiation
occurs within tal1-deﬁcient endocardial cells, we employed the Tg
(myl7:H2A-mCherry) transgene as a reporter of myocardial gene
expression. At 60 hpf, we readily observed Tg(myl7:H2A-mCherry)
expression within the tal1-deﬁcient endocardium; these Tg(myl7:
H2A-mCherry)-expressing cells also expressed Tg(ﬂi1a:nEGFP) and
were located within the endocardial aggregate inside the ventricle
(Fig. 7C and D; n¼26/29). In contrast, we never detected Tg(myl7:
H2A-mCherry) expression within the wild-type endocardium
(Fig. 7A and B; n¼0/23). In addition, we used the MF20 antibody
to visualize the localization of sarcomeric myosin heavy chain.
Similar to our observations using Tg(myl7:H2A-mcherry), we
observed ectopic localization of sarcomeric myosin heavy chain
in the tal1-deﬁcient endocardium (Fig. 7F), but not in the wild-
type endocardium (Fig. 7E).
Extension of these studies revealed that ectopic myocardial
gene expression accumulates progressively over time in the tal1-
deﬁcient endocardium. At 24 hpf, we rarely detected Tg(myl7:H2A-
mCherry) expression in tal1-deﬁcient endocardium: on average,
we found ectopic myocardial gene expression in 5% of tal1-
deﬁcient endocardial cells (Fig. 8A, B, and I). As development
proceeds, this percentage progressively increases. At 36 hpf, we
detected Tg(myl7:H2A-mCherry) expression in 27% of tal1-deﬁcient
endocardial cells (Fig. 8C, D, and I); at 48 hpf, this value had
increased to 38% (Fig. 8E, F, and I). By 60 hpf, we routinely
encountered prominent expression of Tg(myl7:H2A-mCherry) in
the majority of tal1-deﬁcient endocardial cells (71%; Fig. 8G–I).
Furthermore, we observed a decrease in the expression of Tg(ﬂi1a:
negfp) in the cells ectopically expressing Tg(myl7:H2A-mCherry)
(Fig. 7B and D). Together, these data demonstrate the importance
of tal1 function for maintenance of endocardial identity through
repression of myocardial gene expression.
Finally, we considered whether the initiation of ectopic myo-
cardial differentiation could underlie the abnormal endocardial
cell behaviors seen in tal1-deﬁcient embryos. Notably, at 24 hpf,
the majority of the endocardial cells in tal1-deﬁcient embryos
displayed defects in ZO-1 localization, while very few of these cells
displayed ectopic myocardial gene expression (Fig. 5E and F).
Additionally, the onset of aberrant intercellular contacts and ZO-
1 localization (17–18 hpf, Figs. 4 and 6) precedes the onset of the
appearance of ectopic Tg(myl7:H2A-mCherry) expression in the
tal1-deﬁcient endocardium (24 hpf; Fig. 8A, B, and I). Furthermore,
we found that hand2, a bHLH transcription factor gene essential
for robust myocardial differentiation (Schoenebeck et al., 2007;
Yelon et al., 2000), is not required for the aggregation of endo-
cardial cells in tal1-deﬁcient embryos (Fig. S3). We have previously
shown that hand2 (han) mutants display a dramatic reduction in
the number of myocardial cells as well as a minor defect in the
formation of the posterior portion of the endocardial sheet
(Garavito-Aguilar et al., 2010; Schoenebeck et al., 2007; Yelon
et al., 2000). Strikingly, we observed that embryos deﬁcient for
both han and tal1 exhibit multi-layered endocardial aggregates
similar to those seen in tal1-deﬁcient embryos, whereas the
endocardium in han mutants forms a single-layered sheet with
relatively normal spacing between endocardial cells (Fig. S3).
Fig. 6. Endocardial intercellular junctions are disorganized during early endocardial morphogenesis in tal1-deﬁcient embryos. (A–H) Transverse sections of wild-type (A, C,
D, and G) and tal1-deﬁcient embryos (B, E, F, and H), dorsal to the top, at 18s. Immunoﬂuorescence detects localization of ZO-1 (red) (C–H) and F-actin (blue) (D and F); in
addition, an anti-GFP antibody allows visualization of Tg(kdrl:GRCFP) expression (green) in the endocardium (A, B, G, and H). The boxed areas in (A and B) are highlighted in
(C–H). (A) Wild-type endocardium forms a single-layered sheet with ZO-1 localized to discrete puncta at cell-cell contacts (C, D, and G). (B) tal1-deﬁcient endocardium is
multi-layered and disorganized, and ZO-1 is mislocalized in multiple puncta along the endocardial cell boundaries (E, F, and H). (G' and H') Cartoons indicate regions of ZO-1
(red) and F-actin (blue) localization within the endocardium.
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Fig. 7. Myocardial genes are ectopically expressed in the tal1-deﬁcient endocardium at 60 hpf. (A–D) Three-dimensional reconstructions of confocal stacks (A and C) and single
optical sections through the ventricle (B and D) depict wild-type (A and B) and tal1-deﬁcient hearts (C and D) expressing Tg(myl7:H2A-mCherry) (red) and Tg(ﬂi1a:negfp) (green) at
60 hpf, arterial pole at the top. Many tal1-deﬁcient endocardial cells express both Tg(myl7:H2A-mCherry) and Tg(ﬂi1a:negfp) (D), but wild-type endocardial cells express only Tg
(ﬂi1a:negfp) (B). (E and F) Immunoﬂuorescence with the monoclonal antibody MF20 detects sarcomeric myosin heavy chain localization (blue) in wild-type (E) and tal1-deﬁcient
hearts (F) expressing Tg(myl7:H2A-mCherry) (red) and Tg(ﬂi1a:negfp) (green). Optical sections through the ventricle reveal ectopic sarcomeric myosin heavy chain within the tal1-
deﬁcient endocardium (F). In contrast, sarcomeric myosin heavy chain is not found in the wild-type endocardium (E); section shown depicts both the atrial endocardium (bottom)
and outﬂow tract endocardium (top). (B', D', and F') Images display only the myocardial markers from the sections shown in (B, D, and F).
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Fig. 8. Ectopic myocardial gene expression progressively increases within the tal1-deﬁcient endocardium. (A–H) Optical sections from confocal stacks of wild-type (A, C, E, and G)
and tal1-deﬁcient (B, D, F, and H) hearts expressing Tg(myl7:H2A-mCherry) (red) and Tg(ﬂi1a:negfp) (green) at 24 hpf (A and B), 36 hpf (C and D), 48 hpf (E and F) and 60 hpf (G and
H), arterial pole at the top. These representative hearts demonstrate the progressive increase in the percentage of endocardial cells expressing Tg(myl7:H2A-mCherry) that occurs
between 24 and 60 hpf in tal1-deﬁcient embryos (B, D, F, and H). In contrast, the wild-type endocardium never expresses Tg(myl7:H2A-mCherry) (A, C, E, and G). (B', D', F', and H')
Images display only the myocardial marker from the sections shown in (B, D, F, and H). Arrows indicate examples of endocardial cells ectopically expressing Tg(myl7:H2A-mCherry).
(I) Bar graph depicts the average percentage of tal1-deﬁcient endocardial cells expressing Tg(myl7:H2A-mCherry) at each stage examined. Error bars indicate standard deviation
(n¼4–8 embryos per stage).
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These data indicate that the aggregation of the tal1-deﬁcient
endocardium does not require hand2 function and suggest that
this aggregation is not a consequence of ectopic myocardial
differentiation. Together, these experiments suggest that tal1
could play independent roles in regulating endocardial morpho-
genesis and inhibiting myocardial gene expression.
Discussion
Taken together, our studies of tal1-deﬁcient embryos illuminate
several intriguing elements of endocardial morphogenesis. Our
data reveal a cell-autonomous requirement for Tal1 function
during endocardial tube extension and point to a cell-intrinsic
inﬂuence of Tal1 on the regulation of endocardial cell–cell con-
tacts. In addition, our results provide the ﬁrst demonstration that
Tal1 function has a signiﬁcant impact on the localization of
endocardial intercellular junctions within the endocardial sheet
at the embryonic midline. Moreover, our work highlights the
importance of endocardial sheet architecture as a key prerequisite
for proper endocardial tube formation.
Although prior studies in zebraﬁsh have tracked the trajectories of
endocardial cells while they migrate to the midline, the mechanisms
controlling endocardial cell behavior during tube formation are not
well understood (Bussmann et al., 2007; Proulx et al., 2010; Veerkamp
et al., 2013). It is therefore particularly interesting that the endocardial
tube defects in tal1-deﬁcient embryos originate with inappropriate
cell–cell contacts within the endocardial sheet at the midline. Without
Tal1 function, endocardial cells migrate to the midline normally but
then do not spread out into a single layer of ﬂattened, endothelium-
like tissue; instead, they create a cluster of irregularly stacked, cuboidal
cells. Importantly, the failure of tal1-deﬁcient endocardial cells to form
a normally elongated tube appears to be a consequence of their early
disorganization; once clustered together, the tal1-deﬁcient endocardial
cells exhibit no apparent inclination toward populating the atrium. At
the same time, the relatively normal length of the tal1-deﬁcient
myocardial tube suggests that, even though endocardium–myocar-
dium interactions are important for several aspects of heart develop-
ment (Chang et al., 2004; de la Pompa and Epstein, 2012; Garavito-
Aguilar et al., 2010; Holtzman et al., 2007; Stankunas et al., 2008;
Totong et al., 2011; Wagner and Siddiqui, 2007), the process of
myocardial tube elongation is largely independent from endocardial
tube elongation. The derailment of endocardial tube formation by the
defective architecture of the midline sheet strongly suggests that the
sheet is an important intermediate structure during endocardial
morphogenesis. We propose that formation of the endocardial sheet
represents a fundamental transition in cell behavior, as endocardial
cells shift frommigrating as individuals to moving as a cohesive group,
and that this transition is crucial for the elongation of the endo-
cardial tube.
Regulation of intercellular junction formation is likely to con-
tribute to the coordination of endocardial sheet architecture, and
our data provide striking evidence for the inﬂuence of Tal1 on the
organization of endocardial cell–cell junctions. In the tal1-deﬁ-
cient endocardial sheet, junctions form at inappropriate subcel-
lular locations and cells aggregate in abnormal conﬁgurations. Our
mosaic studies suggest the possibility that Tal1 regulates cell-
intrinsic aspects of junction component localization; however, it is
also feasible that the irregular distribution of junctions in the
tal1-deﬁcient endocardium reﬂects a secondary consequence of
misregulation of another cell behavior such as migration or
establishment of polarity. Additionally, although our data docu-
ment the impact of Tal1 on the distribution of the tight junction
component ZO-1, we speculate that additional components of
intercellular junctions are likely to be disorganized in tal1-deﬁ-
cient embryos, including components of the adherens junctions,
especially since adherens junctions have been shown to regulate
tight junction establishment in cultured epithelial cells (Deleuze
et al., 2007; Fanning and Anderson, 2009; Hartsock and Nelson,
2008; Taddei et al., 2008). In future studies, it will be valuable to
acquire a deeper understanding of the molecular mechanisms
underlying endocardial cell–cell interactions and to evaluate
whether or not Tal1 has a direct inﬂuence on transcription of
any of the key players.
In addition to its importance in organizing the morphology of the
endocardial sheet, Tal1 is important for the maintenance of the
endocardial differentiation program. Previously, we have shown that
tal1 and estrp contribute to ALPM patterning by repressing cardiac
progenitor speciﬁcation and promoting vascular and hematopoietic
speciﬁcation (Schoenebeck et al., 2007). However, our prior work did
not evaluate how each of these genes contributes to the progression
of endocardial differentiation. Our current data show that, as devel-
opment progresses, the tal1-deﬁcient endocardium fails to maintain
its identity and gradually accumulates myocardial characteristics.
These results reinforce the conclusions reached from recent studies
that revealed ectopic myocardial differentiation in the endocardium
of Tal1 mutant mice (Van Handel et al., 2012). The failure of tal1-
deﬁcient embryos to maintain endocardial identity may reﬂect the
early role of tal1 in repressing cardiac speciﬁcation in the ALPM or
may be due to a distinct, later role of tal1. Recent work has also
demonstrated the importance of etsrp for promoting endocardial
differentiation and repressing myocardial differentiation (Palencia-
Desai et al., 2011; Rasmussen et al., 2011). However, etsrp may act at
an earlier stage than tal1, since loss of etsrp function seems to inhibit
the initiation, rather than the maintenance, of endocardial gene
expression (Palencia-Desai et al., 2011; Rasmussen et al., 2011).
The failure of endocardial cells to maintain their identity in
tal1-deﬁcient embryos raises the possibility that their cell behavior
problems are merely secondary to the misexpression of myocar-
dial genes in the endocardium. Since we observe temporal
separation between the sudden, early onset of defects in junction
formation and the gradual, later appearance of ectopic myocardial
differentiation, we propose a model in which Tal1 has distinct
roles in regulating the formation of endocardial intercellular
junctions and maintaining endocardial identity. However, we also
acknowledge the possibility that the identity transformation in
tal1-deﬁcient endocardium begins prior to the expression of the
myocardial markers that we have examined and that the earlier
expression of particular myocardial genes, such as myocardium-
speciﬁc adhesion molecules, could interfere with endocardial
sheet formation. Evaluation of this model will require future
elucidation of the precise kinetics of ectopic myocardial gene
expression in the tal1-deﬁcient endocardium.
Overall, our studies provide the ﬁrst integration of two
disparate and previously noted roles of Tal1 – the role of Tal1 in
promoting endocardial tube elongation (Bussmann et al., 2007)
and its role in repressing myocardial differentiation within the
endocardium (Schoenebeck et al., 2007; Van Handel et al., 2012) –
and provide higher resolution of the temporal dynamics of each of
these Tal1 functions. The synthesis of our data suggests the
possibility that Tal1 plays independent roles in endocardial junc-
tion organization and endocardial identity preservation but also
leaves open the possibility that these functions are interconnected.
Future studies focused on the identiﬁcation of relevant Tal1 targets
will be essential to determine whether each of the roles of Tal1 are
executed by distinct downstream pathways.
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